Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study T Sokka, H Kautiainen, T Pincus, SMM Verstappen, A Aggarwal, R Alten, ... Arthritis research & therapy 12, 1-10, 2010 | 363 | 2010 |
Reliability and validity of the University of California, Los Angeles scleroderma clinical trial consortium gastrointestinal tract instrument D Khanna, RD Hays, P Maranian, JR Seibold, A Impens, MD Mayes, ... Arthritis Care & Research: Official Journal of the American College of …, 2009 | 245 | 2009 |
Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1β, and tumour necrosis factor α in the bronchoalveolar lavage fluid, peripheral blood, and skin of … MR Hussein, HI Hassan, ERM Hofny, M Elkholy, NA Fatehy, ... Journal of clinical pathology 58 (2), 178-184, 2005 | 112 | 2005 |
Phenotypes determined by cluster analysis and their survival in the prospective European scleroderma trials and research cohort of patients with systemic sclerosis V Sobanski, J Giovannelli, Y Allanore, G Riemekasten, P Airò, S Vettori, ... Arthritis & rheumatology 71 (9), 1553-1570, 2019 | 92 | 2019 |
Tendon transfer around the shoulder in obstetric brachial plexus paralysis: clinical and computed tomographic study TA El-Gammal, WR Saleh, A El-Sayed, MM Kotb, HM Imam, NA Fathi Journal of Pediatric Orthopaedics 26 (5), 641-646, 2006 | 69 | 2006 |
Amyloid arthropathy associated with multiple myeloma: a systematic analysis of 101 reported cases AM Elsaman, AR Radwan, MK Akmatov, C Della Beffa, A Walker, ... Seminars in Arthritis and Rheumatism 43 (3), 405-412, 2013 | 41 | 2013 |
Glomerular expression and elevated serum Bcl-2 and Fas proteins in lupus nephritis: preliminary findings NA Fathi, MR Hussein, HI Hassan, E Mosad, H Galal, NA Afifi Clinical & Experimental Immunology 146 (2), 339-343, 2006 | 41 | 2006 |
Longitudinal measurement of methotrexate liver concentrations does not correlate with liver damage, clinical efficacy, or toxicity during a 3.5 year double blind study in … NH Fathi, F Mitros, J Hoffman, N Straniero, D Labreque, R Koehnke, ... The Journal of Rheumatology 29 (10), 2092-2098, 2002 | 40 | 2002 |
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study VK Jaeger, M Tikly, D Xu, E Siegert, E Hachulla, P Airò, G Valentini, ... Rheumatology 59 (7), 1684-1694, 2020 | 39 | 2020 |
Diagnostic performance and predictive value of rheumatoid factor, anti-cyclic-citrullinated peptide antibodies and HLA-DRB1 locus genes in rheumatoid arthritis NA Fathi, AM Ezz-Eldin, E Mosad, RM Bakry, HB Hamed, S Ahmed, ... International archives of medicine 1, 1-7, 2008 | 31 | 2008 |
Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort C Mihai, O Distler, AM Gheorghiu, PI Constantin, R Dobrota, S Jordan, ... Rheumatology 59 (8), 2016-2023, 2020 | 20 | 2020 |
High-resolution manometry compared with the University of California Los Angeles Scleroderma Clinical Trials Consortium GIT 2.0 in Systemic Sclerosis g Hanan Sayed M. Abozaid, MDa, n, Hala M.K. Imam, MDb, Marwa Mahmoud ... Seminarsin Arthritisand Rheumatism, 2017 | 20 | 2017 |
Egyptian consensus on treat-to-target approach for osteoporosis: a clinical practice guideline from the Egyptian Academy of bone health and metabolic bone diseases Y El Miedany, MH Abu-Zaid, M El Gaafary, MMH El Naby, N Fathi, ... Egyptian Rheumatology and Rehabilitation 48, 1-16, 2021 | 19 | 2021 |
Serum and urinary biomarkers endothelin-1, beta-2 microglobulin, cystatin C, galectin-3 and alpha-1-acid glycoprotein; can they surrogate clinical and histological staging in … EAE Tony, H Mohammed, N Fathi, AA Tony, O Afifi, MAA Abdou, A Fehr J Arthritis 5 (223), 2, 2016 | 12 | 2016 |
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region A Lescoat, D Huscher, N Schoof, P Airò, J de Vries-Bouwstra, ... Rheumatology 62 (6), 2178-2188, 2023 | 10 | 2023 |
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort M Elhai, N Sritharan, M Boubaya, A Balbir-Gurman, E Siegert, E Hachulla, ... The Lancet Rheumatology 4 (11), e785-e794, 2022 | 9 | 2022 |
Cohort enrichment strategies for progressive interstitial lung disease in systemic sclerosis from European Scleroderma Trials and Research AM Hoffmann-Vold, C Brunborg, P Airò, LP Ananyeva, L Czirják, ... Chest 163 (3), 586-598, 2023 | 8 | 2023 |
Osteoporosis treatment gap in patients at risk of fracture in Egypt: a multi-center, cross-sectional observational study Y El Miedany, M El Gaafary, N Gadallah, S Mahran, N Fathi, MH Abu Zaid, ... Archives of Osteoporosis 18 (1), 58, 2023 | 7 | 2023 |
Hypo-vitaminosis D in patients with rheumatoid arthritis, systemic lupus erythematosus and ankylosing spondylitis MI Kareem, RH Mohammed, HS Abozaid, MM Rayan, AM Mohamed, ... J Clin Cell Immunol 6 (369), 2, 2015 | 7 | 2015 |
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model A Garaiman, K Steigmiller, C Gebhard, C Mihai, R Dobrota, C Bruni, ... Rheumatology 62 (SI), SI91-SI100, 2023 | 6 | 2023 |